{"id":"W4402559951","doi":"10.1016/j.annonc.2024.08.799","title":"737P Characterization of tumor response with lenvatinib plus pembrolizumab (LEN + Pembro) in the ENGOT-en9/LEAP-001 study","year":2024,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":false,"ca_institutions":"Sunnybrook Health Science Centre","funders":"","keywords":"Medicine; Pembrolizumab; Lenvatinib; Oncology; Internal medicine; Cancer; Immunotherapy; Thyroid cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00112036,0.0004302867,0.0006305258,0.0002275735,0.0002176419,0.0009547435,0.0004205644,0.0005037793,0.002796179],"category_scores_gemma":[0.0009470225,0.0001890696,0.0009809032,0.0004428143,0.00027408,0.0006819779,0.0003404089,0.0009850299,0.0008295655],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0004996731,"about_ca_system_score_gemma":0.0003387614,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006344849,"about_ca_topic_score_gemma":0.0009816987,"domain_scores_codex":[0.9994234,0.0002079614,0.00003509486,0.0001587278,0.00008461779,0.00009023027],"domain_scores_gemma":[0.9995574,0.0001197918,0.0001259761,0.0000532122,0.00005445435,0.00008911884],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1945183,0.001706899,0.6586816,0.0006678344,0.006737495,0.0006811023,0.0001561285,0.002021184,0.02205956,0.0007636115,0.007143827,0.1048626],"study_design_scores_gemma":[0.009149727,0.01977093,0.9379088,0.00009448934,0.004247998,0.0009464396,0.0002318782,0.002867057,0.005837631,0.001263824,0.01762911,0.00005200109],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9888204,0.001835478,0.0005207569,0.0003400038,0.00007904845,0.0001090372,0.004040788,0.0000220114,0.004232517],"genre_scores_gemma":[0.9930902,0.0002978212,0.0002837221,0.0002623247,0.00005914169,0.0001113821,0.004119454,0.00002023574,0.00175567],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002796179,"threshold_uncertainty_score":0.009354115,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06545529475976408,"score_gpt":0.380701236339212,"score_spread":0.315245941579448,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}